Gastrointestinal Bleeding News and Research

RSS
Gastrointestinal bleeding or gastrointestinal hemorrhage describes every form of hemorrhage (loss of blood) in the gastrointestinal tract, from the pharynx to the rectum.
RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

New therapeutic target can prevent abnormal blood vessel growth that causes gastrointestinal bleeding

New therapeutic target can prevent abnormal blood vessel growth that causes gastrointestinal bleeding

Identifying new mechanism for aspirin in cancer prevention

Identifying new mechanism for aspirin in cancer prevention

Hospital evidence-based practice centers can effectively inform decision-making in medical settings

Hospital evidence-based practice centers can effectively inform decision-making in medical settings

Mercy open new Endoscopy Suite to promote and practice gastrointestinal health

Mercy open new Endoscopy Suite to promote and practice gastrointestinal health

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Obesity raises Lynch syndrome CRC risk

Obesity raises Lynch syndrome CRC risk

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Restrictive policies for blood transfusions could produce significant cost savings for NHS

Restrictive policies for blood transfusions could produce significant cost savings for NHS

Daily dose of aspirin effective at blocking breast tumor growth

Daily dose of aspirin effective at blocking breast tumor growth

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes  in CLL/SLL patients

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Updated data from PROCLAIM national patient registry presented at 51st ASCO

Updated data from PROCLAIM national patient registry presented at 51st ASCO

Current menopausal hormone therapy users at increased risk of experiencing GI bleeding

Current menopausal hormone therapy users at increased risk of experiencing GI bleeding

Ibrutinib (IMBRUVICA) may be effective for pancreatic ductal adenocarcinoma

Ibrutinib (IMBRUVICA) may be effective for pancreatic ductal adenocarcinoma

Aspirin use continues to surge among older adults in US

Aspirin use continues to surge among older adults in US

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients